150
Participants
Start Date
January 31, 2005
Primary Completion Date
April 30, 2007
Study Completion Date
April 30, 2007
vinflunine
solution for injection, IV, 280/320 mg/m2, every 3 wks, variable duration
Local Institution, Beverly Hills
Local Institution, La Jolla
Local Institution, Los Angeles
Local Institution, Santa Monica
Local Institution, Stanford
Local Institution, Vallejo
Local Institution, Aurora
Local Institution, New Haven
Local Institution, Washington D.C.
Local Institution, Jacksonville
Local Institution, Miami
Local Institution, Atlanta
Local Institution, Honolulu
Local Institution, Chicago
Local Institution, Joliet
Local Institution, Urbana
Local Institution, Louisville
Local Institution, Baltimore
Local Institution, Burlington
Local Institution, Ann Arbor
Local Institution, Detroit
Local Institution, Kansas City
Local Institution, St Louis
Local Institution, Las Vegas
Local Institution, Lebanon
Local Institution, Buffalo
Local Institution, New York
Local Institution, The Bronx
Local Institution, Charlotte
Local Institution, Durham
Local Institution, Cincinnati
Local Institution, Philadelphia
Local Institution, Pittsburgh
Local Institution, Providence
Local Institution, Nashville
Local Institution, Dallas
Local Institution, Seattle
Local Institution, Milwaukee
Local Institution, Liverpool
Local Institution, Sydney
Local Institution, Taree
Local Institution, Waratah
Local Institution, Westmead
Local Institution, Adelaide
Local Institution, Linz
Local Institution, Salzburg
Local Institution, Edmonton
Local Institution, London
Local Insitution, Toronto
Local Institution, Montreal
Local Institution, Caen
Local Institution, Le Mans
Local Institution, Nice
Local Institution, Paris
Local Institution, Toulouse
Local Institution, Nea Liosia
Local Institution, Jakarta
Local Institution, Genova
Local Institution, Milan
Local Institution, Roma
Local Institution, Rome
Local Institution, Viterbo
Local Institution, Cebu City
Local Institution, Quezon
Local Institution, Quezon City
Local Institution, Singapore
Local Institution, Seoul
Local Institution, Murcia
Local Institution, Palma de Mallorca
Local Institution, Santander
Local Institution, Seville
Local Institution, Linköping
Local Institution, Uppsala
Local Institution, Aarau
Local Institution, Bangkok
Lead Sponsor
Pierre Fabre Medicament
INDUSTRY
Bristol-Myers Squibb
INDUSTRY